Form 4: Nano-X CFO Ran Daniel Granted 39,474 RSUs

Nano-X Imaging Ltd.'s CFO, Daniel Ran, was granted 39,474 restricted share units, increasing his beneficial ownership.

Summary

• Daniel Ran, CFO of Nano-X Imaging Ltd., acquired 39,474 ordinary shares underlying restricted share units (RSUs).
• The grant date for these RSUs was March 18, 2026.
• These RSUs will vest in two tranches: 50% on March 18, 2027 (12-month anniversary) and the remaining 50% on March 18, 2028 (24-month anniversary).
• Following this transaction, Daniel Ran beneficially owns 46,424 ordinary shares.
• The transaction price for the acquisition of these shares was $0, typical for RSU grants.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive alignment with shareholder interests through equity incentives, which is a standard and healthy corporate governance practice.

Positives

• The grant of restricted share units to the CFO aligns management's interests with long-term shareholder value.
• Increased beneficial ownership by a key executive can signal confidence in the company's future prospects.

Future Outlook

The vesting schedule for the RSUs indicates a long-term incentive structure for the CFO, aligning his compensation with the company's performance over the next two years.

Industry Context

StockSavvy.ai notes that executive compensation, particularly through equity grants like RSUs, is a common practice in the medical imaging technology sector to attract and retain top talent and incentivize long-term performance. This aligns Nano-X's executive incentives with industry standards for growth-oriented tech companies.

Comparison to Industry Standards

• The use of restricted share units (RSUs) for executive compensation is a standard practice across the technology and healthcare sectors, comparable to companies like Siemens Healthineers, GE Healthcare, and Philips, which also utilize equity-based incentives to align executive interests with shareholder value.
• The two-year vesting schedule (50% at 12 months, 50% at 24 months) is a common structure for executive equity grants, designed to promote retention and long-term performance, similar to vesting schedules observed at peer companies in the medical device and imaging space.

Stakeholder Impact

• Shareholders: Potentially positive, as executive compensation tied to equity can align management's long-term interests with shareholder value.
• Employees: No direct impact mentioned, but a well-compensated executive team can contribute to overall company stability and success.

Next Steps

• First tranche of RSUs will vest on March 18, 2027.
• Second tranche of RSUs will vest on March 18, 2028.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted stock units to the CFO, which is a standard component of executive compensation. While it indicates continued alignment of management's interests with shareholders, it does not present new information significant enough to warrant a change in investment recommendation. It's a neutral to slightly positive event that reinforces a 'hold' stance for investors already in Nano-X Imaging Ltd.

Keywords

Nano-X Imaging, NNOX, Form 4, Restricted Share Units, RSU, Executive Compensation, Insider Ownership, Daniel Ran, CFO